CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01794793
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:09.830615+00:00
Published At: 2024-08-28T00:00:00+00:00
Record Updated At: 2024-10-01
Results Posted At: 2024-08-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cushing\u0027s Disease", "Acromegaly", "Neuroendocrine Tumors", "Pituitary Tumors", "Ectopic ACTH Secreting (EAS) Tumors", "Dumping Syndrome", "Prostate Cancer", "Melanoma Negative for bRAF", "Melanoma Negative for nRAS"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-10-01"
protocolSection.identificationModule.nctId: "NCT01794793"
protocolSection.identificationModule.officialTitle: "An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-08-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.